T1 Intervention 1685 1697 mitochondria
T2 Biomarker 1249 1257 dopamine
T4 Biomarker 1447 1455 dopamine
T5 Gene 822 834 cytochrome c
T6 Level 1568 1580  tumor cells
T7 Biomarker 1338 1346 dopamine
T8 Protein 869 872 p50
T9 Condition 94 110 malignant glioma
T10 Cancer cells 1531 1566 p50/p65 NF-κB nuclear localization 
T11 Condition 435 440 tumor
T12 Condition 606 611 tumor
T13 Biomarker 530 538 dopamine
T14 Condition 654 660 glioma
T15 Biomarker 335 343 Dopamine
T16 Biomarker 1763 1771 dopamine
T18 Level 1535 1580 p65 NF-κB nuclear localization in tumor cells
T20 Intervention 1685 1698 mitochondrial
T21 Biomarker 635 643 dopamine
T22 Condition 1231 1236 tumor
T23 Condition 1614 1619 tumor
T24 Level 1165 1185 U87MG and U251 cells
T25 Biomarker 725 733 dopamine
T26 Gene 1073 1077 gene
T27 Condition 542 548 glioma
T28 Level 790 802 glioma cells
T29 Gene 1383 1395 cytochrome c
T31 Intervention 749 755 colony
T32 Intervention 852 864 mitochondria
T33 Condition 790 796 glioma
T34 Biomarker 453 461 dopamine
T35 Organism 1639 1653 xenograft mice
T36 Protein 1480 1508 inflammation-related protein
T37 Protein 635 665 dopamine inhibited glioma cell
T38 Level 877 892 p65 subcellular
T39 Condition 1569 1574 tumor
T40 Organism 1279 1293 xenograft mice
T41 Condition 1811 1823 human glioma
T42 Condition 321 326 tumor
T43 Gene 1121 1132 p65 nuclear
T44 Protein 1117 1120 p50
T45 Protein 1531 1534 p50
T46 Condition 36 42 cancer
T47 Protein 1041 1068 inflammatory marker protein
T48 Biomarker 1204 1212 dopamine
T49 Biomarker 205 213 Dopamine
T50 Biomarker 217 257 monoamine catecholamine neurotransmitter
